Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


1 Acad Radiol
1 Biochem Biophys Res Commun
1 Br J Cancer
1 Cancer Commun (Lond)
1 Ceylon Med J
1 Eur Urol
1 Int J Cancer
1 Int J Clin Oncol
1 J Clin Imaging Sci
1 J Endourol
1 Med Sci Monit
1 Oncotarget
1 Rev Mal Respir
1 Sci Rep
1 Technol Health Care
1 Urol Int
1 Urol Oncol
2 World J Urol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acad Radiol

  1. WANG Y, Hu D, Yu H, Shen Y, et al
    Comparison of the Diagnostic Value of Monoexponential, Biexponential, and Stretched Exponential Diffusion-weighted MRI in Differentiating Tumor Stage and Histological Grade of Bladder Cancer.
    Acad Radiol. 2018 May 9. pii: S1076-6332(18)30199.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  2. ZHU X, Li Y, Zhao S, Zhao S, et al
    LSINCT5 activates Wnt/beta-catenin signaling by interacting with NCYM to promote bladder cancer progression.
    Biochem Biophys Res Commun. 2018 May 14. pii: S0006-291X(18)31133.
    PubMed     Text format     Abstract available

    Br J Cancer

  3. MASON SJ, Downing A, Wright P, Hounsome L, et al
    Health-related quality of life after treatment for bladder cancer in England.
    Br J Cancer. 2018 May 14. pii: 10.1038/s41416-018-0084.
    PubMed     Text format     Abstract available

    Cancer Commun (Lond)

  4. LAM TBL
    Optimizing the diagnosis of pelvic lymph node metastasis in bladder cancer using computed tomography and magnetic resonance imaging.
    Cancer Commun (Lond). 2018;38:2.
    PubMed     Text format    

    Ceylon Med J

  5. GOONEWARDENA SAS, Jayarajah U, Kuruppu SN, Herath HMKB, et al
    Clinical outcomes in a cohort of patients with T1 high grade urothelial bladder cancer not receiving intravesical bacillus Calmette-Guerin: a 15 year experience
    Ceylon Med J. 2018;63:37-39.
    PubMed     Text format    

    Eur Urol

  6. PANEBIANCO V, Narumi Y, Altun E, Bochner BH, et al
    Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).
    Eur Urol. 2018 May 10. pii: S0302-2838(18)30335.
    PubMed     Text format     Abstract available

    Int J Cancer

  7. TELEKA S, Haggstrom C, Nagel G, Bjorge T, et al
    Risk of bladder cancer by disease severity in relation to metabolic factors and smoking; a prospective pooled cohort study of 800,000 men and women.
    Int J Cancer. 2018 May 14. doi: 10.1002/ijc.31597.
    PubMed     Text format     Abstract available

    Int J Clin Oncol

  8. BABA M, Kageyama S, Yoshida T, Fujiwara R, et al
    Intravesical bacillus Calmette-Guerin therapy after second transurethral resection for primary T1 bladder cancer.
    Int J Clin Oncol. 2018 May 14. pii: 10.1007/s10147-018-1292.
    PubMed     Text format     Abstract available

    J Clin Imaging Sci

  9. TRAN-HARDING K, Nair RT, Ganesh H
    Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer.
    J Clin Imaging Sci. 2018;8:18.
    PubMed     Text format     Abstract available

    J Endourol

  10. LI R, Petros FG, Davis JW
    Extended Pelvic Lymph Node Dissection in Bladder Cancer.
    J Endourol. 2018;32.
    PubMed     Text format     Abstract available

    Med Sci Monit

  11. LIU XP, Yin XH, Yan XH, Zeng XT, et al
    The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer.
    Med Sci Monit. 2018;24:3113-3118.
    PubMed     Text format     Abstract available


  12. PARDINI B, Cordero F, Naccarati A, Viberti C, et al
    microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes.
    Oncotarget. 2018;9:20658-20669.
    PubMed     Text format     Abstract available

    Rev Mal Respir

  13. LEVI L, Groh M, De Castro N, Bergeron A, et al
    [BCG infection following intravesicular immunotherapy for bladder cancer].
    Rev Mal Respir. 2018 May 10. pii: S0761-8425(18)30073.
    PubMed     Text format     Abstract available

    Sci Rep

  14. GE P, Wang L, Lu M, Mao L, et al
    Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Sci Rep. 2018;8:7543.
    PubMed     Text format     Abstract available

    Technol Health Care

  15. XU W, Xia H, Liu W, Zheng W, et al
    Exploration of genetics commonness between bladder cancer and breast cancer based on a silcio analysis on disease subtypes.
    Technol Health Care. 2018 Apr 27. pii: THC174699. doi: 10.3233/THC-174699.
    PubMed     Text format     Abstract available

    Urol Int

  16. DRAEGER DL, Sievert KD, Hakenberg OW
    Psychosocial Distress in Bladder Cancer Stratified by Gender, Age, Treatment, and Tumour Stage.
    Urol Int. 2018 May 14:1-7. doi: 10.1159/000489502.
    PubMed     Text format     Abstract available

    Urol Oncol

  17. WOOLBRIGHT BL, Ayres M, Taylor JA 3rd
    Metabolic changes in bladder cancer.
    Urol Oncol. 2018 May 14. pii: S1078-1439(18)30132.
    PubMed     Text format     Abstract available

    World J Urol

  18. FALKE J, Hulsbergen-van de Kaa CA, Maj R, Oosterwijk E, et al
    A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model.
    World J Urol. 2018 May 16. pii: 10.1007/s00345-018-2334.
    PubMed     Text format     Abstract available

  19. MARTIN JW, Vernez SL, Lotan Y, Abdelhalim A, et al
    Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
    World J Urol. 2018 May 14. pii: 10.1007/s00345-018-2331.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.